NORTHERN TRUST CORP - CATALYST BIOSCIENCES INC ownership

CATALYST BIOSCIENCES INC's ticker is CBIO and the CUSIP is 14888D208. A total of 82 filers reported holding CATALYST BIOSCIENCES INC in Q4 2020. The put-call ratio across all filers is 0.04 and the average weighting 0.1%.

Quarter-by-quarter ownership
NORTHERN TRUST CORP ownership history of CATALYST BIOSCIENCES INC
ValueSharesWeighting
Q3 2023$41,677
+37.2%
86,4120.0%0.00%
Q2 2023$30,382
+69.9%
86,4120.0%0.00%
Q1 2023$17,887
-60.8%
86,4120.0%0.00%
Q4 2022$45,582
+3.6%
86,4120.0%0.00%
Q3 2022$44,000
-70.7%
86,412
+2.2%
0.00%
Q2 2022$150,000
+172.7%
84,531
+1.0%
0.00%
Q1 2022$55,000
-40.9%
83,688
-18.1%
0.00%
Q4 2021$93,000
-78.1%
102,156
-1.2%
0.00%
Q3 2021$425,000
-8.2%
103,370
-3.3%
0.00%
Q2 2021$463,000
-72.7%
106,943
-68.2%
0.00%
Q1 2021$1,694,000
-12.7%
336,232
+9.3%
0.00%
Q4 2020$1,941,000
+38.9%
307,669
-5.4%
0.00%
Q3 2020$1,397,000
-17.6%
325,123
+12.5%
0.00%
Q2 2020$1,696,000
+254.1%
288,878
+163.6%
0.00%
Q1 2020$479,000
-32.1%
109,590
+5.9%
0.00%
Q4 2019$705,000
+52.9%
103,476
+10.3%
0.00%
Q3 2019$461,000
-60.9%
93,833
-41.4%
0.00%
Q2 2019$1,179,000
-12.2%
160,083
-3.3%
0.00%
Q1 2019$1,343,000
+11.7%
165,631
+8.8%
0.00%
Q4 2018$1,202,000
-17.8%
152,246
+12.3%
0.00%
Q3 2018$1,462,000
-3.6%
135,631
+4.4%
0.00%
Q2 2018$1,516,000
+130.0%
129,896
+408.3%
0.00%
Q1 2018$659,000
+260.1%
25,556
+91.0%
0.00%
Q4 2017$183,00013,3780.00%
Other shareholders
CATALYST BIOSCIENCES INC shareholders Q4 2020
NameSharesValueWeighting ↓
JOHNSON & JOHNSON 66,951$13,8590.01%
Colorado Capital Management, Inc. 34,165$70.01%
Nantahala Capital Management 160,430$33,2090.00%
Kynam Capital Management, LP 89,886$18,6060.00%
Keebeck Wealth Management, LLC 20,000$4,1400.00%
MORGAN STANLEY 38,404$7,9500.00%
ACADIAN ASSET MANAGEMENT LLC 259,467$520.00%
BlackRock Inc. 169,904$35,1700.00%
Bank of New York Mellon Corp 200,638$41,5320.00%
Citadel Advisors 5,700$1,1800.00%
View complete list of CATALYST BIOSCIENCES INC shareholders